Zoetis Inc. (ZTS)
$74.30-1.78%Close
BUYRECOVERY · day 5
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $31.1B
- Beta
- 0.74
- Div yield
- 3.53%
- P/E (TTM)
- 12.22
- Short % float
- 4.40%
- Days to cover
- 4.1
- SI change
- +6.0%
- 1W
- +4.16%
- 1M
- +0.86%
- vs SPY 1W
- +4.30%
- vs SPY 1M
- -1.65%
Industry peers
FMP comparable companies · ranked by market cap
- MRKSELLMerck & Co., Inc.$359.2BBEARQ 11$145.45-2.39%
- IDXXBUYIDEXX Laboratories, Inc.$41.3BRECOVERYQ 29$523.94-0.69%
- ELANSELLElanco Animal Health Incorporated$11.3BRECOVERYQ 2$22.56-0.66%
- NEOGSELLNeogen Corporation$2.6BBEARQ 16$12.00-2.25%
- PAHCBUYPhibro Animal Health Corporation$1.5BRECOVERYQ 10$37.43-1.66%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on ZTS?
- LOPJLB’s latest quantitative signal on Zoetis Inc. (ZTS) is BUY in a RECOVERY regime. Signals are updated daily.
- What market regime is ZTS in?
- Zoetis Inc. (ZTS) is currently classified in the RECOVERY HMM market regime on LOPJLB.
- What does Zoetis Inc. (ZTS) do?
- Zoetis Inc. stands as a global leader in animal health, focusing on the research, development, manufacturing, and commercialization of veterinary pharmaceuticals, vaccines, and diagnostic tools. Its comprehensive portfolio serves a broad spectrum of species, encompassing both livestock, including cattle, swine, poultry, fish, and sheep, and beloved companion animals such as dogs, cats, and hors…